Xenetic Biosciences Inc
XBIO
Get informed when a big investor buys or sells
+ FollowMarket Cap$5.62M
Close$
$7.48
272.3% upside
Current Fair Value
272.3% upsideUndervalued by 272.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $5.62 Million |
|---|---|
| Enterprise Value | $-846,811.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.58 |
| Beta | 2.2 |
| Outstanding Shares | 2,294,364 |
Return
| Return on Equity | -40.76% |
|---|---|
| Return on Assets | -35.52% |
| Return on Invested Capital | -42.92% |
Valuation & Multiples
| P/E Ratio | -1.79 |
|---|---|
| PEG | -5.12 |
| Price to Sales | 2.01 |
| Price to Book Ratio | 1.01 |
| Enterprise Value to Revenue | -0.26 |
| Enterprise Value to EBIT | 0.32 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Xenetic Biosciences Inc
2,018 employees